Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE-the largest cooperative study of population-based cancer survival in Europe-has shown persistent differences between countries for cancer survival, although in general, cancer survival is improving. Major changes in cancer diagnosis, treatment, and rehabilitation occurred in the early 2000s. EUROCARE-5 assesses their effect on cancer survival in 29 European countries.
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study / De Angelis R, S.M., Coleman, M.p., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., Bielska Lasota, M., Engholm, G., Nennecke, A., Siesling, S., Berrino, F., M, C.R.H., Zielonke, N., Oberaigner, W., Henau, K., Van Eycken, E., Dimitrova, N., et al.. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - ELETTRONICO. - 15:1(2014), pp. 23-34. [10.1016/S1470-2045(13)70546-1]
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study
PONZ DE LEON, Maurizio;FEDERICO, Massimo;
2014
Abstract
Cancer survival is a key measure of the effectiveness of health-care systems. EUROCARE-the largest cooperative study of population-based cancer survival in Europe-has shown persistent differences between countries for cancer survival, although in general, cancer survival is improving. Major changes in cancer diagnosis, treatment, and rehabilitation occurred in the early 2000s. EUROCARE-5 assesses their effect on cancer survival in 29 European countries.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1470204513705461-main.pdf
Accesso riservato
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
327.13 kB
Formato
Adobe PDF
|
327.13 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




